Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-157-7 | CAS number: 52-89-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-11-28 - 2012-12-18
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- L-Cysteine Hydrochloride Monohydrate
- Cas Number:
- 175.63
- Molecular formula:
- C3H7NO2S·HCl·H2O
- IUPAC Name:
- L-Cysteine Hydrochloride Monohydrate
- Test material form:
- solid: granular
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- - Source: Harlan Laboratories B.V., Postbus 6174, Nl-5960 AD Horst/ The Netherlands
- Age at study initiation: 8 -9 weeks
- Weight at study initiation: 18.7 - 24.0 g
- Housing: The animals were kept singly in MAKROLON cages (type III) with a basal surface of approx. 39 cm X 23 cm and a height of approx. 15 cm. - Bedding: Granulated soft wood bedding
- Diet (ad libitum): 2018C Teklad Global 18 % protein rodent diet
- Water (ad libitum): Tap water
ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3 °C (maximum range)
- Relative humidity: 20.7 - 91 % (maximum range)
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- other: ethanol : water (3+7,v/v)
- Concentration:
- 0 % w/w, 10 % w/w, 25 % w/w, and 50 % w/w
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
A preliminary experiment was carried out in 2 animals to examine the irritating potential and handling/ application of the test item in order to select the appropriate concentrations. Two concentrations of 25 and 50% of l-cysteine hydrochlorid monohydrate in ethanol : water (3+7,v/v) were examined.
Results:
In the preliminary experiment, concentrations of 25% and 50%, employing 1 animal per concentration,
were examined. No pronounced irritating properties were observed in this preliminary experiment at concentrations of 25% or 50%, no differences in ear weight and ear thickness were noted.
MAIN STUDY:
The test item was suspended in a mixture of ethanol : water (3+7,v/v).
The test item suspension was administered to the dorsum of animal's ears at an application volume of 25 μL/ear.
The concentrations were chosen based on a preliminary dose range finding.
The experimental schedule of the assay was as follows:
Each test group of mice was treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 0, 10, 25 and 50 % (w/w). The application volume, 25 µl/ear/day,
was spread over the entire dorsal surface of each ear once daily for three consecutive days. Five
days after the first topical application 250 µl of phosphate-bufffered saline containing 19.7 µCi of 3Hmethyl thymidine was injected into each mouse via tail vein.
Approximately 5 hours after the intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were
prepared from pooled lymph nodes, which were subsequently washed and incubated withe trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl-thymidine measured in a beta-scintillation counter.
The clinical signs were recorded at least once daily, especially the treatment sites were observed carefully.
Day 1:
The weight of each animal was individually identified and recorded. The ear thickness was measured.
Open application of 25 μL of the appropriate dilution of the test item or the vehicle alone were applied to the dorsum of each ear.
Days 2 and 3:
The application procedure carried out on day 1 was repeated. On day 3 the ear thickness was measured.
Day 5: 48 hours after the last application the animals were sacrificed.
Ear swelling measurements (immediately before sacrificing the mice) were carried out.
Punch biopsies were prepared and immediately weighed on an analytical balance.
ANALYSIS OF RESULTS:
A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentrations resulted in a 3-fold or greater increase in incorporation of 3H-methyl thymidine compared with concurrent controls, as indicated by the Stimulation Index. The estimated concentration of test item required to produce a Stimulation Index of 3 is referred as the EC3 value. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables.
Results and discussion
- Positive control results:
- The positive control was performed in October 2012. The expected increases in the Stimulation Index were observed (S.I. = 5.7 in 25% (w/v) Positive control item concentration). Therefore, the study could be regarded as valid.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 2.3
- Test group / Remarks:
- 50%
- Remarks on result:
- other: Values above 3 are considered positive (these values were fixed empirically during the interlaboratory validation of this method)
- Parameter:
- SI
- Value:
- 2
- Test group / Remarks:
- 10%
- Remarks on result:
- other: Values above 3 are considered positive (these values were fixed empirically during the interlaboratory validation of this method)
Any other information on results incl. tables
disintegrations per minute (DPM)
0 % 95.6
10% 195.8
25 % 219.4
50 % 234.7
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the present test conditions, L-Cysteine hydrochloride monohydrate at concentrations of 10%,
25% or 50% (w/w) in ethanol : water (3+7,v/v) did not reveal sensitising properties in the local lymph node assay. - Executive summary:
L-Cysteine hydrochloride monohydrate was suspended in a mixture of ethanol : water (3+7,v/v). The vehicle was selected on the basis of maximising contact of the test item with the skin. The test item suspension was administered to the dorsum of the animal's ears. The concentrations were chosen based on a preliminary dose range finding. The experimental schedule of the assay was as follows:
Each test group of 4 female mice was treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 0, 10, 25 and 50 % (w/w). The application volume, 25 µl/ear/day, was spread over the entire dorsal surface of each ear once daily for three consecutive days. Five days after the first topical application 250 µl of phosphate-buffered saline containing 19.7 µCi of 3Hmethyl thymidine was injected into each mouse via tail vein. Approximately 5 hours after the intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group.
Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated withe trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl-thymidine measured in a beta-scintillation counter.
The clinical signs were recorded at least once daily, especially the treatment sites were observed carefully.
Day 1: The weight of each animal was individually identified and recorded. The ear thickness was measured. Open application of 25 μL of the appropriate dilution of the test item or the vehicle alone were applied to the dorsum of each ear.
Days 2 and 3: The application procedure carried out on day 1 was repeated. On day 3 the ear thickness
was measured.
Day 5: 48 hours after the last application the animals were sacrificed. Ear swelling measurements (immediately before sacrificing the mice) were carried out. Punch biopsies were prepared and immediately weighed on an analytical balance.
A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentrations resulted in a 3-fold or greater increase in incorporation of 3H-methyl thymidine compared with concurrent controls, as indicated by the Stimulation Index.
Results: No deaths occurred during the study periods. No symptoms of local skin irritation at the ears of the animals and no signs of systemic toxicity were observed during the study period. The body weight of the animals was within the range commonly recorded for animals of this strain and age.
Stimulation Indices of 2.0, 2.3 and 2.3 were determined with test item concentrations of 10, 25 and 50%. The threshold value for a sentisizer of 3 is not reached. L-Cysteine hydrochloride monohydrate is classified as not sensitizing.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.